Analysis of the samples by RNA sequencing (RNA-seq) was performed to identify RNAs that could be used to separate FSHD patients from healthy controls, and to propose biomarkers for DUX4 lowering approaches. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.